combination therapy

Research in Review
Transplantation After High-Dose Chemo Effective in Treating Multiple Myeloma
04/19/2017
JCP Editors
Adult patients with multiple myeloma who receive a high-dose chemotherapy regimen plus autologous stem-cell transplantation improve their median progression-free survival (PFS) by 14 months compared with patients who...
Adult patients with multiple myeloma who receive a high-dose chemotherapy regimen plus autologous stem-cell transplantation improve their median progression-free survival (PFS) by 14 months compared with patients who...
Adult...
04/19/2017
Journal of Clinical Pathways
Research in Review
Novel Therapy Plus Gemcitabine Does Not Improve OS in Pancreatic Cancer
04/11/2017
JCP Editors
A new tyrosine kinase inhibitor (TKI) in combination with gemcitabine does not improve overall survival (OS) any more than gemcitabine alone for patients with advanced pancreatic cancer, according to research...
A new tyrosine kinase inhibitor (TKI) in combination with gemcitabine does not improve overall survival (OS) any more than gemcitabine alone for patients with advanced pancreatic cancer, according to research...
A new...
04/11/2017
Journal of Clinical Pathways
Research in Review
Combination Therapy Improves Efficacy of B-Cell Lymphoma Treatment
03/20/2017
JCP Editors
Combining two treatment strategies for the treatment of B-cell lymphoma may be more effective than either strategy alone, according to a study published in Cell Reports (February 28,...
Combining two treatment strategies for the treatment of B-cell lymphoma may be more effective than either strategy alone, according to a study published in Cell Reports (February 28,...
...
03/20/2017
Journal of Clinical Pathways
Research in Review
Combination Therapy Improves Outcomes for Patients With CLL
03/10/2017
JCP Editors
The addition of a novel monoclonal antibody to ibrutinib significantly improves survival outcomes for patients with previously treated high-risk chronic lymphocytic leukemia (CLL), according to the results of a phase...
The addition of a novel monoclonal antibody to ibrutinib significantly improves survival outcomes for patients with previously treated high-risk chronic lymphocytic leukemia (CLL), according to the results of a phase...
The...
03/10/2017
Journal of Clinical Pathways
Research in Review
Novel TKI Therapy Plus Gemcitabine Does Not Improve OS in Pancreatic Cancer
03/09/2017
JCP Editors
A new tyrosine kinase inhibitor (TKI) in combination with gemcitabine does not improve overall survival (OS) any more than gemcitabine alone for patients with advanced pancreatic cancer, according to a study...
A new tyrosine kinase inhibitor (TKI) in combination with gemcitabine does not improve overall survival (OS) any more than gemcitabine alone for patients with advanced pancreatic cancer, according to a study...
A new...
03/09/2017
Journal of Clinical Pathways
Research in Review
Consolidation Therapy With Chemo Improves Survival for Patients With CLL
03/06/2017
JCP Editors
An intravenous consolidation regimen developed for patients with chronic lymphocytic leukemia (CLL) was found to be safe and effective, according to a report in the European Journal of...
An intravenous consolidation regimen developed for patients with chronic lymphocytic leukemia (CLL) was found to be safe and effective, according to a report in the European Journal of...
An...
03/06/2017
Journal of Clinical Pathways
Research in Review
Adding Androgens to Maintenance Therapy Improves Survival in Older Patients With AML
03/01/2017
JCP Editors
Maintenance therapy with androgens significantly improves survival in older patients with acute myeloid leukemia (AML) without increasing toxicity, according to research published in the Journal of Clinical Oncology...
Maintenance therapy with androgens significantly improves survival in older patients with acute myeloid leukemia (AML) without increasing toxicity, according to research published in the Journal of Clinical Oncology...
...
03/01/2017
Journal of Clinical Pathways
Research in Review
Radiotherapy Combined With Delayed Surgery Reduces Adverse Effects of Rectal Cancer Treatment
02/13/2017
JCP Editors
Short-course preoperative radiotherapy combined with delayed surgery reduces the adverse effects of rectal cancer surgery while maintaining its efficiency, according to a study published in The Lancet (published...
Short-course preoperative radiotherapy combined with delayed surgery reduces the adverse effects of rectal cancer surgery while maintaining its efficiency, according to a study published in The Lancet (published...
...
02/13/2017
Journal of Clinical Pathways
Research in Review
Combination Treatment Improves Survival for BRAF-Mutant Metastatic Colorectal Cancer
01/26/2017
JCP Editors
The addition of BRAF-inhibitor vemurafenib to irinotecan and cetuximab chemotherapy treatment improves progression-free survival (PFS) for patients with BRAF-mutant metastatic colorectal cancer, according to a...
The addition of BRAF-inhibitor vemurafenib to irinotecan and cetuximab chemotherapy treatment improves progression-free survival (PFS) for patients with BRAF-mutant metastatic colorectal cancer, according to a...
The...
01/26/2017
Journal of Clinical Pathways
Research in Review
PET Scans During Induction Chemo Contribute to Complete Response for Esophageal Cancer
01/19/2017
JCP Editors
Positron emission tomography (PET) scans during induction chemotherapy for esophageal cancer helps assess patient response to treatment and adjust their therapy, which could lead to an improved complete response rate...
Positron emission tomography (PET) scans during induction chemotherapy for esophageal cancer helps assess patient response to treatment and adjust their therapy, which could lead to an improved complete response rate...
...
01/19/2017
Journal of Clinical Pathways

Upcoming Events

February 2 ⁠–⁠ February 5
Western AF Symposium
February 27 ⁠–⁠ March 1
DCLF
March 17 ⁠–⁠ March 19
NP Institute
March 27 ⁠–⁠ March 30
TCIV
March 31 ⁠–⁠ April 2
Rx summit logo
April 21 ⁠–⁠ April 24
SAWC Spring
April 30 ⁠–⁠ May 4
Symposium on Advanced Wound Care
April 30 ⁠–⁠ May 5
WoundCon
May 1 ⁠–⁠ May 3
Senior Living Executive Conference
May 19 ⁠–⁠ May 21
See Full Calendar

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use